Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mexiletine in non-dystrophic myotonia
2010-020923-37Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of mexiletine in non-dystrophic myotonia (NDM), myotonia congenita (MC) and paramyotonia congenita (PMC), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Severity of myotonia by visual analogue scale. Started Jul 2010; status: active.
02
Drugs
mexiletine
03
Conditions
non-dystrophic myotonia (NDM)myotonia congenita (MC)paramyotonia congenita (PMC)
Beyond the preview
Go deeper on 2010-020923-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020923-37.